Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000150:complications / Q000628:therapy*; D002339:Carotid Arteries; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008353:Mannitol / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D015376:Nimustine; D009607:Nitrosourea Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D009837:Oligodendroglioma / Q000150:complications / Q000628:therapy*; D009886:Ophthalmoplegia / Q000209:etiology; D014786:Vision Disorders / Q000209:etiology*
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D015376:Nimustine; D008353:Mannitol